⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Ceredyn Biotechnology and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Ceredyn Biotechnology is a medical technology company specializing in the development of advanced solutions for hydrocephalus therapy. Their primary product focus includes the HAKIM 3 Programmable Valve System, which is designed to manage cerebrospinal fluid pressure in patients.
The company is dedicated to innovation in neurosurgical devices, specifically targeting the treatment of hydrocephalus. Their product suite includes programmable valves, programmers, and pressure monitoring systems to improve patient outcomes in complex neurological care.
CLASSIFICATION
Company Type:MedTech
Therapeutic Areas:
Industry:Medical Devices
Sub-Industry:Neurosurgery / Hydrocephalus
SIZE & FINANCIALS
Ownership:private
Status:operating
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial
Modalities:Medical Device
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
COMPETITION
Position:Niche Player
LINKS
Website:cere-dyn.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Ceredyn Biotechnology. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.